SOUTHFIELD, Mich. – (March 31, 2010) – Lumigen HyPerBlu, a novel chemiluminescent substrate from Beckman Coulter, Inc., enables direct detection of hydrogen peroxide. Combining a broad dynamic range and bright, sustained chemiluminescence, the ready-to-use reagent offers unmatched convenience for high-throughput screening laboratories.
Reaction of the substrate with hydrogen peroxide rapidly generates sustained high-intensity luminescence for maximum sensitivity in solution assays. Direct detection increases accuracy and simplifies data analysis. When coupled with oxidases, the reagent also allows reliable, one-step, indirect detection of oxidases or their substrates.
HyPerBlu is provided as a single solution and does not require mixing. It is stable for one year when stored in an amber bottle at 2-8 degrees C.
“Detection of hydrogen peroxide is an important and widely used component of the drug discovery process,” noted Ed Pagani, vice president and general manager of molecular diagnostics, Beckman Coulter, Inc. “HyPerBlu saves time and delivers accurate results, qualities that should be highly desirable to researchers in high-throughput screening laboratories.”
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.
Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc.
